doi: 10.1007/BF00915410.
Effect of two gold compounds on human polymorphonuclear leukocyte lysosomal function and phagocytosis
- PMID: 3920144
- DOI: 10.1007/BF00915410
Item in Clipboard
Effect of two gold compounds on human polymorphonuclear leukocyte lysosomal function and phagocytosis
Inflammation.
1985 Mar.
Abstract
Lysosomal neutral proteases, once released, are considered to play an important role in the rheumatoid inflammatory process. The effect of two gold compounds on human polymorphonuclear lysosomal enzymes was studied during reverse endocytosis. Phagocytosis was assessed using dual-labeled liposomes. Auranofin, a new antirheumatic gold compound, reduces human polymorphonuclear leukocyte phagocytoses and lysosomal elastase and beta-glucuronidase release at a therapeutically achievable concentration (5 microM). Sodium aurothiomalate was ineffective at this concentration.
Similar articles
-
Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent.Inflammation. 1977 Jun;2(2):131-42. doi: 10.1007/BF00918675. Inflammation. 1977. PMID: 104927
-
Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects.Inflammation. 1986 Sep;10(3):311-20. doi: 10.1007/BF00916126. Inflammation. 1986. PMID: 3017859
-
Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.J Lab Clin Med. 1982 Jul;100(1):37-44. J Lab Clin Med. 1982. PMID: 6283001
-
Biologic actions and pharmacokinetic studies of auranofin.Am J Med. 1983 Dec 30;75(6A):90-108. doi: 10.1016/0002-9343(83)90481-3. Am J Med. 1983. PMID: 6318557 Review.
-
[Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].Med Clin (Barc). 1985 May 25;84(20):834-9. Med Clin (Barc). 1985. PMID: 3928990 Review. Spanish. No abstract available.